Timber Pharma slips ahead of shareholder vote on merger

seekingalpha2023-11-17

Timber Pharmaceuticals (NYSE:TMBR) fell ~16% in the early hours on Thursday ahead of a special meeting scheduled later this week to obtain shareholder approval for its proposed merger with Danish ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2384739028?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097298712/image_1097298712.jpg","is_english":true,"pubTime":"2023-11-17 00:32","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2384739028","market":"us","top_or_hot":-1,"title":"Timber Pharma slips ahead of shareholder vote on merger","media":"seekingalpha","content":"<div>\n<p>Timber Pharmaceuticals (NYSE:TMBR) fell ~16% in the early hours on Thursday ahead of a special meeting scheduled later this week to obtain shareholder approval for its proposed merger with Danish ...</p>\n\n<a href=\"https://seekingalpha.com/news/4037742-timber-pharma-stock-down-shareholder-vote-merger\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Timber Pharma slips ahead of shareholder vote on merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTimber Pharma slips ahead of shareholder vote on merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-17 00:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4037742-timber-pharma-stock-down-shareholder-vote-merger><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Timber Pharmaceuticals (NYSE:TMBR) fell ~16% in the early hours on Thursday ahead of a special meeting scheduled later this week to obtain shareholder approval for its proposed merger with Danish ...</p>\n\n<a href=\"https://seekingalpha.com/news/4037742-timber-pharma-stock-down-shareholder-vote-merger\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://seekingalpha.com/news/4037742-timber-pharma-stock-down-shareholder-vote-merger","article_id":"2384739028","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097298712/image_1097298712.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2384739028","pubTimestamp":1700152324,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Timber Pharmaceuticals (NYSE:TMBR) fell ~16% in the early hours on Thursday ahead of a special meeting scheduled later this week to obtain shareholder approval for its proposed merger with Danish derm","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药"},"translate_title":"木材制药在股东投票决定合并前下滑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMBR":1},"content_text":"Timber Pharmaceuticals (NYSE:TMBR) fell ~16% in the early hours on Thursday ahead of a special meeting scheduled later this week to obtain shareholder approval for its proposed merger with Danish dermatology company LEO Pharma. Shares of the nano-cap pharma company surged in August in reaction to the deal under which LEO US Holding, a unit of LEO Pharma, is set to acquire TMBR for $14M in upfront cash and an additional $22M in contingent value rights ((CVRs)). However, since then, the stock has lost ~34%, as the company’s previous attempt to obtain shareholder approval in October failed amid insufficient votes at a special meeting. The latest meeting, scheduled for November 17 at 12:00 p.m., “could very well be the last opportunity for shareholders to accept LEO Pharma’s offer before the merger is finally terminated,” Seeking Alpha analyst Bart van Velzen argues. The analyst who owns Timber (TMBR) shares points to millions of dollars LEO has agreed to provide as bridge financing for the company. If “shareholders do not approve the merger, Timber immediately owes LEO Pharma an amount of money from the loan it will not be able to pay back and will likely have to declare bankruptcy,” Velzen warned.  More on Timber Pharma  Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance Timber to be taken private by LEO Pharma, stock soars 100% Seeking Alpha’s Quant Rating on Timber Pharmaceuticals Historical earnings data for Timber Pharmaceuticals Financial information for Timber Pharmaceuticals","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2384739028"}